MediMuse
Engineering Software · 1-10 Employees
View Company Info for Free
Overview
Website
www.medimuse.netRevenue
<$5 MillionIndustry
About MediMuse
Is MediMuse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
MediMuse, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once MediMuse has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at MediMuse
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on MediMuse recently announced quarterly report
Check if MediMuse has recently received funding, and reach out quickly before it becomes old news!
Check out if MediMuse is spiking on competitors!
Product Launch: Get notified when MediMuse launches new products
Click to see if MediMuse had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined MediMuse as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
MediMuse is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
MediMuse is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about MediMuse.
MediMuse Tech Stack
A closer look at the technologies used by MediMuse
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MediMuse
MediMuse LLC specializes in transforming biometric data into music through its patented StateSong technology, which serves as a biofeedback tool to help users achieve desired mental and physical states. The company offers APIs, libraries, and a cloud platform that enable users to create and share personalized music based on their emotional and phys... Read More